TNFAIP3 mutation may be associated with favorable overall survival for patients with T-cell lymphoma

Transcriptome-Based Co-Expression of BRD4 and PD-1/PD-L1 Predicts Poor Overall Survival in Patients With Acute Myeloid Leukemia

(2021) Cunte Chen et al.   Frontiers in Pharmacology

Inhibition of BCL11B induces downregulation of PTK7 and results in growth retardation and apoptosis in T-cell acute lymphoblastic leukemia

(2021) Kehan Li et al.   Biomarker Research

The prognostic significance of del6q23 in chronic lymphocytic leukemia

(2021) Hadiyah Y. Audil et al.   AMERICAN JOURNAL OF HEMATOLOGY

Tumor mutation burden estimated by a 69-gene-panel is associated with overall survival in patients with diffuse large B-cell lymphoma

(2021) Cunte Chen et al.   Experimental Hematology & Oncology

High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B‐cell lymphomas

(2020) Visar Vela et al.   HEMATOLOGICAL ONCOLOGY

Expression patterns of immune checkpoints in acute myeloid leukemia

(2020) Cunte Chen et al.   Journal of Hematology & Oncology

Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making

(2020) Si-Ye Chen et al.   LEUKEMIA

ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma

(2019) Yalu Liu et al.   Cancer Cell International

Comparison of the NCCN-IPI, the IPI and PIT scores as prognostic tools in peripheral T-cell lymphomas

(2019) Fredrik Ellin et al.   BRITISH JOURNAL OF HAEMATOLOGY

Activation of the NF-κB Pathway and Heterozygous Deletion of TNFAIP3 (A20) Confer Superior Survival in Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type

(2019) Fang Liu et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Aggressive T‐ cell Lymphomas: 2019 updates on diagnosis, risk stratification and management

(2019) Jasmine M. Zain   AMERICAN JOURNAL OF HEMATOLOGY

Molecular pathogenic pathways in extranodal NK/T cell lymphoma

(2019) Sanjay de Mel et al.   Journal of Hematology & Oncology

The potential role of TNFAIP3 in malignant transformation of gastric carcinoma

(2019) Bing Du et al.   PATHOLOGY RESEARCH AND PRACTICE

T-cell therapies for T-cell lymphoma

(2019) Keri Toner et al.   CYTOTHERAPY

The predictive value of dynamic monitoring of peripheral blood lymphocyte to monocyte ratio in patients with extranodal NK/T cell lymphoma

(2019) Shengnan Zhang et al.   Cancer Cell International

Stat3 mutations impact on overall survival in large granular lymphocyte leukemia: a single-center experience of 205 patients

(2019) Gregorio Barilà et al.   LEUKEMIA

Clinicopathologic implications of TNFAIP3/A20 deletions in extranodal NK/T-cell lymphoma

(2018) Hyein Ahn et al.   GENES CHROMOSOMES & CANCER

Loss of TNFAIP3 enhances MYD88L265P-driven signaling in non-Hodgkin lymphoma

(2018) Kerstin Wenzl et al.   Blood Cancer Journal

A20 promotes metastasis of aggressive basal-like breast cancers through multi-monoubiquitylation of Snail1

(2017) Ji-Hyung Lee et al.   NATURE CELL BIOLOGY

Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms

(2017) Manli Jiang et al.   Expert Review of Hematology

The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma

(2016) Dai Chihara et al.   BRITISH JOURNAL OF HAEMATOLOGY

TNFAIP3 promotes survival of CD4 T cells by restricting MTOR and promoting autophagy

(2015) Yu Matsuzawa et al.   Autophagy

Characteristics of A20 gene polymorphisms and clinical significance in patients with rheumatoid arthritis

(2015) Lihua Zhu et al.   Journal of Translational Medicine

Characteristics of A20 gene polymorphisms in T-cell acute lymphocytic leukemia

(2014) Lihua Zhu et al.   Hematology

A20-mediated negative regulation of canonical NF-κB signaling pathway

(2013) Rajeshree Pujari et al.   IMMUNOLOGIC RESEARCH

Clinicopathologic implication of A20/TNFAIP3 deletion in diffuse large B-cell lymphoma: an analysis according to immunohistochemical subgroups and rituximab treatment

(2013) Jin Ho Paik et al.   LEUKEMIA & LYMPHOMA

The role of A20 in the pathogenesis of lymphocytic malignancy

(2012) Fan Zhang et al.   Cancer Cell International

Genetic variation and alterations of genes involved in NFκB/TNFAIP3- and NLRP3-inflammasome signaling affect susceptibility and outcome of colorectal cancer

(2012) Jonas Ungerbäck et al.   CARCINOGENESIS

Prognosis of mature T cell lymphoma is poorer than that of diffuse large B cell lymphoma in IPI low-risk group, but not in intermediate- and high-risk groups

(2012) Rika Kihara et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sézary syndrome

(2011) F C M Braun et al.   LEUKEMIA

Analysis of a French cohort of patients with large granular lymphocyte leukemia: a report on 229 cases

(2010) B. Bareau et al.   HAEMATOLOGICA

The NF- B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas

(2009) U. Novak et al.   BLOOD

The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: An overview with emphasis on the myeloid neoplasms

(2009) James W. Vardiman   CHEMICO-BIOLOGICAL INTERACTIONS